82 related articles for article (PubMed ID: 4347078)
1. Human brain and platelet cyclic adenosine 3',5'-monophosphate phosphodiesterases: different response to drugs.
Pichard AL; Hanoune J; Kaplan JC
Biochim Biophys Acta; 1972 Aug; 279(1):217-20. PubMed ID: 4347078
[No Abstract] [Full Text] [Related]
2. Relative potencies of dipyridamole and related agents as inhibitors of cyclic nucleotide phosphodiesterases: possible explanation of mechansim of inhibition of platelet function.
McElroy FA; Philip RB
Life Sci; 1975 Nov; 17(9):1479-93. PubMed ID: 173959
[No Abstract] [Full Text] [Related]
3. Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.
Asano T; Ochiai Y; Hidaka H
Mol Pharmacol; 1977 May; 13(3):400-6. PubMed ID: 195193
[No Abstract] [Full Text] [Related]
4. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase.
Smith JB; Mills DC
Biochem J; 1970 Dec; 120(4):20P. PubMed ID: 4322637
[No Abstract] [Full Text] [Related]
5. Targeting phosphodiesterases in anti-platelet therapy.
Rondina MT; Weyrich AS
Handb Exp Pharmacol; 2012; (210):225-38. PubMed ID: 22918733
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet cyclic 3',5'-adenosine-monophosphate phosphodiesterases by pentifylline.
Stefanovich V
Arzneimittelforschung; 1975 May; 25(5):740-1. PubMed ID: 170944
[TBL] [Abstract][Full Text] [Related]
7. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
Mills DC; Smith JB
Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
[TBL] [Abstract][Full Text] [Related]
8. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
[TBL] [Abstract][Full Text] [Related]
9. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Zahavi M; Zahavi J; Kakkar VV
Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines.
Sawanishi H; Suzuki H; Yamamoto S; Waki Y; Kasugai S; Ohya K; Suzuki N; Miyamoto K; Takagi K
J Med Chem; 1997 Sep; 40(20):3248-53. PubMed ID: 9379444
[TBL] [Abstract][Full Text] [Related]
11. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
Hidaka H; Asano T
Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
[No Abstract] [Full Text] [Related]
13. Potentiation of the effects of exogenously applied ATP and purinergic nerve stimulation on the guinea-pig taenia coli by dipyridamole and hexobendine.
Satchell DG; Lynch A; Bourke PM; Burnstock G
Eur J Pharmacol; 1972 Sep; 19(3):343-50. PubMed ID: 4344978
[No Abstract] [Full Text] [Related]
14. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
Dunkern TR; Hatzelmann A
Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
[TBL] [Abstract][Full Text] [Related]
15. Cyclic GMP binding and phosphodiesterase: implication for platelet function.
Hamet P; Coquil JF; Bousseau-Lafortune S; Franks DJ; Tremblay J
Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():119-36. PubMed ID: 6202123
[No Abstract] [Full Text] [Related]
16. Platelet aggregation. IV. Platelet phosphodiesterase and its inhibition by vasodilators.
Vigdahl RL; Mongin J; Marquis NR
Biochem Biophys Res Commun; 1971 Mar; 42(6):1088-94. PubMed ID: 4323846
[No Abstract] [Full Text] [Related]
17. 9-Benzyladenines: potent and selective cAMP phosphodiesterase inhibitors.
Bourguignon JJ; Désaubry L; Raboisson P; Wermuth CG; Lugnier C
J Med Chem; 1997 Jun; 40(12):1768-70. PubMed ID: 9191951
[No Abstract] [Full Text] [Related]
18. A new cGMP phosphodiesterase isolated from bovine platelets is substrate for cAMP- and cGMP-dependent protein kinases: evidence for a key role in the process of platelet activation.
Robichon A
J Cell Biochem; 1991 Oct; 47(2):147-57. PubMed ID: 1661738
[TBL] [Abstract][Full Text] [Related]
19. [Present status and prospects of platelet inhibitors].
Yasunaga K
Rinsho Ketsueki; 1976 Jun; 17(6):590-9. PubMed ID: 184313
[No Abstract] [Full Text] [Related]
20. Inhibition in vitro of cyclic 3',5' nucleotide phosphodiesterase activity by drugs.
Moffat AC; Patterson DA; Curry AS; Owen P
Eur J Toxicol; 1972; 5(3):160-2. PubMed ID: 4346076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
